MyFinsight
Home
Blog
About
Back
Cash Flow
Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX)
source: myfinsight.com
Net decrease in cash
and cash...
-$11,538,225
(-5.73%↓ Y/Y)
Acquired in-process
research and development...
$6,500,000
Prepaid expenses and
other current assets
-$1,159,729
(-3216.16%↓ Y/Y)
Accounts payable
$822,480
(-14.23%↓ Y/Y)
Share-based compensation
expense
$528,102
(-22.66%↓ Y/Y)
Reduction in the carrying
amount of operating...
$38,826
(-26.38%↓ Y/Y)
Depreciation and
amortization expense
$6,647
(-18.14%↓ Y/Y)
Net cash used in
operating activities
-$7,019,737
(35.38%↑ Y/Y)
Net cash used in
investing activities
-$4,518,488
(-13210.03%↓ Y/Y)
Canceled cashflow
$9,055,784
Net loss
-$14,558,426
(-8.61%↓ Y/Y)
Acquired in-process
research and development
$4,500,000
Purchase of property and
equipment
$18,488
(-45.54%↓ Y/Y)
Accrued expenses and
other current...
-$1,479,663
(-272.93%↓ Y/Y)
Operating lease liability
-$37,432
(28.10%↑ Y/Y)
Back